01.002 RWE TNT JULY 2022 B 14-07-2022

NICE to increase use of real-world evidence

  • NICE plans to use more data resources than just randomized controlled trials (RCTs) this year for submissions
  • MHRA already takes account of real-world studies, in order to facilitate their upcoming 150 day licensing commitments
  • The utilisation of real world data will be key in tackling the funding and access issue surrounding NICE reimbursement

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at